WO1996011562A3 - Gene humain de controle et gene pour l'arn antisens de ce dernier - Google Patents
Gene humain de controle et gene pour l'arn antisens de ce dernier Download PDFInfo
- Publication number
- WO1996011562A3 WO1996011562A3 PCT/US1995/012445 US9512445W WO9611562A3 WO 1996011562 A3 WO1996011562 A3 WO 1996011562A3 US 9512445 W US9512445 W US 9512445W WO 9611562 A3 WO9611562 A3 WO 9611562A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- rap
- antisense rna
- human
- protein
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 108020005544 Antisense RNA Proteins 0.000 title abstract 3
- 239000003184 complementary RNA Substances 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 101000666589 Homo sapiens Telomeric repeat-binding factor 2-interacting protein 1 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000003782 apoptosis assay Methods 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000051978 human TERF2IP Human genes 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000022983 regulation of cell cycle Effects 0.000 abstract 1
- 230000018866 regulation of programmed cell death Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/817,436 US5882880A (en) | 1994-10-11 | 1995-10-11 | Human checkpoint gene and gene for antisense RNA thereof |
AU37306/95A AU3730695A (en) | 1994-10-11 | 1995-10-11 | Human checkpoint gene and gene for antisense RNA thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11123894A IL111238A (en) | 1994-10-11 | 1994-10-11 | Human checkpoint gene and gene for antisense rna thereof |
IL111238 | 1994-10-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996011562A2 WO1996011562A2 (fr) | 1996-04-25 |
WO1996011562A3 true WO1996011562A3 (fr) | 1996-10-24 |
Family
ID=11066634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/012445 WO1996011562A2 (fr) | 1994-10-11 | 1995-10-11 | Gene humain de controle et gene pour l'arn antisens de ce dernier |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3730695A (fr) |
IL (1) | IL111238A (fr) |
WO (1) | WO1996011562A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882880A (en) * | 1994-10-11 | 1999-03-16 | Ramot University Authority For Applied And Industrial Development Ltd. | Human checkpoint gene and gene for antisense RNA thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023571A1 (fr) * | 1992-05-12 | 1993-11-25 | Fred Hutchinson Cancer Research Center | Genes points de controle du cycle cellulaire humain |
-
1994
- 1994-10-11 IL IL11123894A patent/IL111238A/xx not_active IP Right Cessation
-
1995
- 1995-10-11 AU AU37306/95A patent/AU3730695A/en not_active Abandoned
- 1995-10-11 WO PCT/US1995/012445 patent/WO1996011562A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023571A1 (fr) * | 1992-05-12 | 1993-11-25 | Fred Hutchinson Cancer Research Center | Genes points de controle du cycle cellulaire humain |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL "yr12d06.r1 Soares fetal liver spleen 1NFLS Homo sapiens cDNA clone IMAGE:205067 5', mRNA sequence.", XP002005781 * |
JEGGO, P. A. ET AL: "Cloning human DNA repair genes", INT. J. RADIAT. BIOL. (1994), 66(5), 573-7 CODEN: IJRBE7;ISSN: 0955-3002, 1994, XP002005780 * |
KUERBITZ, STEVEN J. ET AL: "Wild-type p53 is a cell cycle checkpoint determinant following irradiation", PROC. NATL. ACAD. SCI. U. S. A. (1992), 89(16), 7491-5 CODEN: PNASA6;ISSN: 0027-8424, 1992, XP002005779 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996011562A2 (fr) | 1996-04-25 |
IL111238A0 (en) | 1994-12-29 |
IL111238A (en) | 2003-05-29 |
AU3730695A (en) | 1996-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005030121A3 (fr) | Composes, compositions et procedes | |
WO1993001286A3 (fr) | Therapie localisee utilisant des oligonucleotides | |
WO2001068912A3 (fr) | Diagnostic d'affections associees a des genes suppresseurs de tumeurs et a des oncogenes | |
WO2001077378A3 (fr) | Diagnostic d'etats pathologiques associes a des adduits d'adn | |
WO2002002809A3 (fr) | Diagnostic de troubles du comportement, de troubles neurologiques et de cancers | |
HU9501963D0 (en) | 7-deazapurine modified oligonucleotides | |
WO2002102981A3 (fr) | Procedes therapeutiques et prophylactiques a base de sir2$g(a) | |
WO2004048551A3 (fr) | Cible destinee a la therapie d'un trouble cognitif | |
WO2002074992A3 (fr) | Gene humain implique dans l'accident vasculaire cerebral | |
DK1053313T3 (da) | Optimerede antisense oligonucleotider komplementære til DNA methyltransferase-sekvenser | |
WO2005059108A3 (fr) | Profils d'expression geniques et procedes d'utilisation | |
WO2001032832A3 (fr) | Modulation antisens de l'expression de la nucleoline | |
AU2003225281A8 (en) | Materials and methods for prevention and treatment of rna viral diseases | |
AU2003213054A8 (en) | Rna interference mediated inhibition of polycomb group protein ezh2 gene expression using short interfering nucleic acid (sina) | |
WO1997022695A3 (fr) | Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer | |
WO2003101386A3 (fr) | Suppresseur kinase de l'inactivation de ras pour traiter la tumorigenese induite par ras | |
WO1998054313A3 (fr) | Sequences genomiques d'adn methyltransferase et oligonucleotides antisens | |
DE69638166D1 (de) | Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken | |
WO1996011562A3 (fr) | Gene humain de controle et gene pour l'arn antisens de ce dernier | |
WO2005056756A3 (fr) | Suppresseur de kinase d'inactivation de ras destine a la therapie de tumorigeneses induites par ras | |
WO1996039501A3 (fr) | Oligonucleotides specifiques contre le papillomavirus humain | |
WO2004096826A3 (fr) | Procede pour l'inhibition selective du gene humain n-myc dans les tumeurs exprimant n-myc au moyen de proteines pna antisens et antigeniques | |
AU6795201A (en) | Nucleic acid sequences and methods for the modification of plant gene expression | |
WO2003080800A3 (fr) | Prevention et traitement de maladies au moyen d'angiogenese et/ou d'antigenes tumoraux | |
EP1015630A4 (fr) | Compositions et procedes permettant d'inhiber l'infection a virus de l'immunodeficience humaine par retro-regulation des genes cellulaires humains |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 08817436 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |